US FDA Quality Metrics Initiative Continues Moving Forward … Quietly
Executive Summary
Despite few public announcements and industry concerns, FDA's Office of Pharmaceutical Quality director says program is not dead.
You may also be interested in...
What Carrots Will US FDA Offer For Quality Management Maturity Participation?
Sector-specific incentives may be necessary, but the FDA has not made a final decision.
US FDA Guidance Production May Be Slowed By New OMB Review Requirement
White House says all guidances, as well as proposed rules, must be submitted to OMB for a determination whether they are major or minor.
Drug Shortages: Is "Buy American" One Solution?
Moving more manufacturing to the US could help increase supply chain reliability, which could prevent or blunt shortages, an industry representative argues.